Stay updated on Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page.

Latest updates to the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe footer site revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content, indicating an access restriction rather than substantive changes to the trial information.SummaryDifference20%

- Check55 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor update to the page. There are no changes to study data, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check69 days agoChange DetectedNew study documents and metadata were added to the page, including the Informed Consent Form (2020-10-01, 1.77MB) and the Study Protocol and SAP, along with related terms and collaboration details. These additions broaden access to official materials and clarify collaborators and regulatory context.SummaryDifference61%

- Check77 days agoChange DetectedThe page's site revision label was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page.